Biotage
Price
Prix
GRAPH PAR
Questions fréquentes
Quel est le bénéfice par action (BPA) de Biotage ?
Quelles sont les évaluations des analystes et le prix cible de l'action Biotage ?
Quel est le chiffre d'affaires de Biotage sur les douze derniers mois ?
Quel est l'EBITDA de Biotage ?
Quel est le flux de trésorerie disponible de Biotage ?
Combien d'employés compte Biotage, et à quel secteur d'activité appartient-elle ?
Finances
- BPA (TTM)
- 0,323
- Recettes (TTM)
- 197,91 M $US
- EBITDA (TTM)
- 47,13 M $US
- Cash-flow disponible (TTM)
- 26,64 M $US
Notes des analystes
L'objectif de prix est de 14,63 $US et l'action est analysée par 1 analystes.
Acheter
0
Hold
1
Vendre
0
Informations
Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.
- Salariés
- 673
- Industries
- Spécialités médicales
- Secteur
- Soins de santé
Identifiant
- ISIN
- SE0000454746
- Ticker primaire
- BIOT